These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation]. Bujanda L, García Bengoechea M, Cilla G, Gil I, yArenas JI. Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540 [Abstract] [Full Text] [Related]
4. [Surface antigen (HBsAg) and core antibody (anti-HBc) in chronic uremia during periodic hemodialysis treatment of hepatitis B patients. Correlation with viral replication markers (HBeAg and DNA polymerase activity)]. Buongiorno R, Dentico P, Santantonio T, Frappampina V, Spinelli A, Amato M, Pastore G. Boll Soc Ital Biol Sper; 1980 Oct 30; 56(20):2076-82. PubMed ID: 7459119 [Abstract] [Full Text] [Related]
8. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses. Perrillo RP, Chau KH, Overby LR, Decker RH. Gastroenterology; 1983 Jul 30; 85(1):163-7. PubMed ID: 6406288 [Abstract] [Full Text] [Related]
9. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV. Tassopoulos NC, Papaevangelou GJ, Roumeliotou-Karayiannis A, Sjogren MH, Engle R, Karpodini E, Purcell RH. Hepatogastroenterology; 1986 Aug 30; 33(4):151-4. PubMed ID: 3758906 [Abstract] [Full Text] [Related]
12. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology. Stroffolini T, Sagnelli E, Rapicetta M, Felaco FM, Filippini P, Annella T, Petruzziello A, Chionne P, Sarrecchia B, Piccinino F. Hepatogastroenterology; 1992 Feb 30; 39(1):62-5. PubMed ID: 1568710 [Abstract] [Full Text] [Related]
13. Presence of HBeAg, DNA polymerase activity, Dane particle in different categories of HBsAg carriers and evidence of hepatitis type B infection in their family contacts. Zanetti AR, Ferroni P. Boll Ist Sieroter Milan; 1977 Mar 31; 56(1):79-86. PubMed ID: 861076 [No Abstract] [Full Text] [Related]
15. [HBeAg and Anti-HBe in various groups of acute hepatitis patients and carriers of HBsAg]. Zanetti AR. Boll Ist Sieroter Milan; 1977 Mar 31; 56(1):74-8. PubMed ID: 861075 [Abstract] [Full Text] [Related]
16. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases]. Takahashi A, Sekiya C, Yazaki Y, Tominaga Y, Oohara K, Ono M, Sato H, Hasebe C, Namiki M. Hokkaido Igaku Zasshi; 1983 Jan 31; 58(1):30-42. PubMed ID: 6840666 [Abstract] [Full Text] [Related]
17. [Clinical, laboratory and liver histology of HBsAg-positive volunteer blood donors in Belo Horizonte, State of Minas Gerais, Brazil]. Paz MO, Galizzi Filho J, Simonetti JP, Simonetti SR, de Santana ZM, Barbosa MM, de Carvalho DG, Toppa NH. Rev Hosp Clin Fac Med Sao Paulo; 1998 Jan 31; 53(6):311-6. PubMed ID: 10413947 [Abstract] [Full Text] [Related]
18. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood. Sodeyama T, Kiyosawa K, Akahane Y, Tanaka E, Wada S, Oike Y, Nakamura M, Yoda H, Imai Y, Gibo Y. Am J Gastroenterol; 1986 Apr 31; 81(4):239-45. PubMed ID: 3962948 [Abstract] [Full Text] [Related]